Scientific Sessions

Gynecologic cancers, including cervical, ovarian, and endometrial cancers, require early detection and advanced treatment approaches to improve patient outcomes. Cervical cancer prevention has been revolutionized by HPV vaccination and routine screening through Pap smears and HPV testing. Ovarian cancer remains challenging due to its late-stage diagnosis, emphasizing the need for improved biomarkers and imaging techniques for early detection. Ongoing research into genetic predisposition and molecular profiling is shaping personalized treatment strategies for uterine and endometrial cancers, enhancing therapeutic precision.

Advancements in gynecologic oncology have introduced innovative treatment options such as immunotherapy and targeted therapy, offering improved efficacy with reduced side effects. HPV-related cancer prevention efforts highlight the importance of vaccination and early intervention. Modern radiation techniques and chemotherapy regimens continue to evolve, providing better tumor control while minimizing toxicity. As research progresses, the integration of precision medicine, novel drug therapies, and minimally invasive surgical techniques is transforming cancer care, offering new hope for patients facing gynecologic malignancies.

• Cervical Cancer: Screening, Prevention, and Treatment
• Ovarian Cancer: Early Detection and Novel Therapies
• Endometrial and Uterine Cancers: Research and Advancements
• HPV and Its Role in Gynecologic Cancer Prevention
• Immunotherapy and Targeted Therapy in Gynecologic Oncology
• Advances in Radiation and Chemotherapy for Gynecologic Malignancies